BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cessna MH, Zhou H, Sanger WG, Perkins SL, Tripp S, Pickering D, Daines C, Coffin CM. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol. 2002;15:931-938. [PMID: 12218210 DOI: 10.1097/01.mp.0000026615.04130.1f] [Cited by in Crossref: 274] [Cited by in F6Publishing: 57] [Article Influence: 14.4] [Reference Citation Analysis]
Number Citing Articles
1 Bourra K, El Mazouz S. [Latissimus dorsi flap in reconstruction following treatment of giant tumor of the abdominal wall: about a rare case]. Pan Afr Med J 2017;27:181. [PMID: 28904708 DOI: 10.11604/pamj.2017.27.181.11028] [Reference Citation Analysis]
2 Yu L, Liu J, Lao IW, Luo Z, Wang J. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature. Diagn Pathol 2016;11:67. [PMID: 27460384 DOI: 10.1186/s13000-016-0517-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
3 Kawaguchi T, Mochizuki K, Kizu T, Miyazaki M, Yakushijin T, Tsutsui S, Morii E, Takehara T. Inflammatory pseudotumor of the liver and spleen diagnosed by percutaneous needle biopsy. World J Gastroenterol 2012; 18(1): 90-95 [PMID: 22228976 DOI: 10.3748/wjg.v18.i1.90] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
4 Mossé YP. Anaplastic Lymphoma Kinase as a Cancer Target in Pediatric Malignancies. Clin Cancer Res 2016;22:546-52. [PMID: 26503946 DOI: 10.1158/1078-0432.CCR-14-1100] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
5 Gonçalves JM, Marola LHG, Vieira DSC, Modolo F, Gondak R. The challenging diagnosis of low-grade myofibroblastic sarcoma: A case report and literature update. Oral Oncology 2022;126:105762. [DOI: 10.1016/j.oraloncology.2022.105762] [Reference Citation Analysis]
6 Fung CK, Chow C, Chan WK, Choi EWK, To KF, Chan JKC, Cheuk W. Spindle cell/sclerosing rhabdomyosarcoma with DCTN1::ALK fusion: broadening the molecular spectrum with potential therapeutic implications. Virchows Arch 2022. [PMID: 35229187 DOI: 10.1007/s00428-022-03305-8] [Reference Citation Analysis]
7 Taylor MS, Chougule A, MacLeay AR, Kurzawa P, Chebib I, Le L, Deshpande V. Morphologic Overlap Between Inflammatory Myofibroblastic Tumor and IgG4-related Disease: Lessons From Next-generation Sequencing. Am J Surg Pathol 2019;43:314-24. [PMID: 30451733 DOI: 10.1097/PAS.0000000000001167] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
8 Singhal N, Agarwal V, Chawla A, Tangri R. Central Nervous System Inflammatory Myofibroblastic Tumor Masquerading as Chronic Suppurative Otitis Media. J Pediatr Neurosci 2017;12:188-91. [PMID: 28904584 DOI: 10.4103/jpn.JPN_95_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Gasparini P, Casanova M, Villa R, Collini P, Alaggio R, Zin A, Bonvini P, Antonescu CR, Boldrini R, Caserini R, Moro M, Centonze G, Meazza C, Massimino M, Bergamaschi L, Luksch R, Chiaravalli S, Bisogno G, Zaffaroni N, Daidone MG, Sozzi G, Ferrari A. Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma. Oncotarget 2016;7:58903-14. [PMID: 27385213 DOI: 10.18632/oncotarget.10368] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
10 Pickett JL, Chou A, Andrici JA, Clarkson A, Sioson L, Sheen A, Reagh J, Najdawi F, Kim Y, Riley D, Maidens J, Nevell D, McIlroy K, Valmadre S, Gard G, Hogg R, Turchini J, Robertson G, Friedlander M, Gill AJ. Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required. Am J Surg Pathol 2017;41:1433-42. [PMID: 28731868 DOI: 10.1097/PAS.0000000000000909] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 5.2] [Reference Citation Analysis]
11 Ezzine-Baccari S, Bacha D, Sassi S, Abouda M, Ghrairi H, Touinsi H, Sassi S. Inflammatory myofibroblastic tumor of the lung: a benign lesion with aggressive behavior. Gen Thorac Cardiovasc Surg 2012;60:531-3. [PMID: 22669624 DOI: 10.1007/s11748-012-0039-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Fu X, Jiang J, Tian XY, Li Z. Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature. Diagn Pathol 2015;10:106. [PMID: 26178751 DOI: 10.1186/s13000-015-0358-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
13 Appak YÇ, Sahin GE, Ayhan S, Taneli C, Kasırga E. Inflammatory myofibroblastic tumor of the colon with an unusual presentation of intestinal intussusception. European J Pediatr Surg Rep 2014;2:54-7. [PMID: 25755972 DOI: 10.1055/s-0034-1370774] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
14 Hallberg B, Palmer RH. Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nat Rev Cancer. 2013;13:685-700. [PMID: 24060861 DOI: 10.1038/nrc3580] [Cited by in Crossref: 344] [Cited by in F6Publishing: 325] [Article Influence: 38.2] [Reference Citation Analysis]
15 Boudhas A, Allaoui M, El Asri F, Rharrassi I, El Ochi MR, Tbouda M, Chahdi H, Al Bouzidi A, Oukabli M. Inflammatory myofibroblastic tumor of the lacrimal gland: case report of an exceptional location. BMC Clin Pathol 2017;17:12. [PMID: 28824333 DOI: 10.1186/s12907-017-0050-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Hameed T, Singh M, Nizam A, Bhatia R, Sawant G. Acute Intestinal Obstruction Due to Ileocolic Intussusception in an Adult; A Rare Presentation of Inflammatory Myofibroblastic Tumor. Am J Case Rep 2020;21:e920438. [PMID: 32102989 DOI: 10.12659/AJCR.920438] [Reference Citation Analysis]
17 Wang X, Zhao X, Chin J, Zhu L, Wang Z, Zhong Z. Recurrent retroperitoneal inflammatory myofibroblastic tumor: A case report. Oncol Lett 2016;12:1535-8. [PMID: 27446466 DOI: 10.3892/ol.2016.4767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Wang Z, Zhao X, Li K, Yao W, Dong K, Xiao X, Zheng S. Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center. Pediatr Surg Int 2016;32:239-43. [PMID: 26590817 DOI: 10.1007/s00383-015-3840-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
19 Hayashi M, Kawakubo H, Mayanagi S, Nakamura R, Suda K, Wada N, Kitagawa Y. Gastric inflammatory myofibroblastic tumor treated with combined laparoscopic and endoscopic gastric wedge resection: a case report. World J Surg Oncol 2018;16:161. [PMID: 30089486 DOI: 10.1186/s12957-018-1460-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Webb TR, Slavish J, George RE, Look AT, Xue L, Jiang Q, Cui X, Rentrop WB, Morris SW. Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy. Expert Rev Anticancer Ther 2009;9:331-56. [PMID: 19275511 DOI: 10.1586/14737140.9.3.331] [Cited by in Crossref: 152] [Cited by in F6Publishing: 138] [Article Influence: 11.7] [Reference Citation Analysis]
21 Liegl-Atzwanger B, Fletcher JA, Fletcher CD. Gastrointestinal stromal tumors. Virchows Arch. 2010;456:111-127. [PMID: 20165865 DOI: 10.1007/s00428-010-0891-y] [Cited by in Crossref: 148] [Cited by in F6Publishing: 131] [Article Influence: 12.3] [Reference Citation Analysis]
22 Tateishi Y, Okudela K, Kawai S, Suzuki T, Umeda S, Matsumura M, Kioi M, Ohashi K. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report. Diagn Pathol 2016;11:132. [PMID: 27846861 DOI: 10.1186/s13000-016-0586-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Piva R, Chiarle R, Manazza AD, Taulli R, Simmons W, Ambrogio C, D'Escamard V, Pellegrino E, Ponzetto C, Palestro G, Inghirami G. Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood 2006;107:689-97. [PMID: 16189272 DOI: 10.1182/blood-2005-05-2125] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 5.5] [Reference Citation Analysis]
24 Peron M, Lovisa F, Poli E, Basso G, Bonvini P. Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors. PLoS One 2015;10:e0132330. [PMID: 26147305 DOI: 10.1371/journal.pone.0132330] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
25 Kim SJ, Moon WK, Kim JH, Cho N, Chang CM. Inflammatory pseudotumor of the breast: a case report with imaging findings. Korean J Radiol 2009;10:515-8. [PMID: 19721838 DOI: 10.3348/kjr.2009.10.5.515] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
26 Costa-Pinho A, Melo RB, Graca L, Lopes JM, Costa-Maia J. Multiple hepatic inflammatory pseudotumours diagnosed after laparoscopic excisional biopsy. J Clin Diagn Res 2013;7:1730-1. [PMID: 24086894 DOI: 10.7860/JCDR/2013/6102.3304] [Reference Citation Analysis]
27 Bhagat P, Bal A, Das A, Singh N, Singh H. Pulmonary inflammatory myofibroblastic tumor and IgG4-related inflammatory pseudotumor: a diagnostic dilemma. Virchows Arch. 2013;463:743-747. [PMID: 24100523 DOI: 10.1007/s00428-013-1493-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
28 Gao J, Yin M, Zhu Y, Gu L, Zhang Y, Li Q, Jia C, Ma Z. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma. BMC Cancer 2013;13:471. [PMID: 24112608 DOI: 10.1186/1471-2407-13-471] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
29 Houben CH, Chan A, Lee KH, Tam YH, To KF, Cheng W, Yeung CK. Inflammatory myofibroblastic tumor of the bladder in children: what can be expected? Pediatr Surg Int 2007;23:815-9. [PMID: 17443333 DOI: 10.1007/s00383-007-1885-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
30 Palmer RH, Vernersson E, Grabbe C, Hallberg B. Anaplastic lymphoma kinase: signalling in development and disease. Biochem J 2009;420:345-61. [PMID: 19459784 DOI: 10.1042/BJ20090387] [Cited by in Crossref: 284] [Cited by in F6Publishing: 144] [Article Influence: 21.8] [Reference Citation Analysis]
31 Kane JR, Lewis N, Lin R, Villa C, Larson A, Wayne JD, Yeldandi AV, Laskin WB. Plexiform fibromyxoma with cotyledon-like serosal growth: A case report of a rare gastric tumor and review of the literature. Oncol Lett. 2016;11:2189-2194. [PMID: 26998147 DOI: 10.3892/ol.2016.4185] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
32 Katakwar A, Gedam BS, Mukewar S, Agasti A. Primary gastric inflammatory myofibroblastic tumor in an adult-case report with brief review. Indian J Surg Oncol 2014;5:66-70. [PMID: 24669167 DOI: 10.1007/s13193-014-0296-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
33 Hanna MG, Najfeld V, Irie HY, Tripodi J, Nayak A. Analysis of ALK gene in 133 patients with breast cancer revealed polysomy of chromosome 2 and no ALK amplification. Springerplus 2015;4:439. [PMID: 26312204 DOI: 10.1186/s40064-015-1235-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
34 Alabbas Z, Issa M, Omran A, Issa R. Mesenteric inflammatory myofibroblastic tumor as a rare cause of small intestinal intussusception. J Surg Case Rep. 2020;2020:rjaa322. [PMID: 32994915 DOI: 10.1093/jscr/rjaa322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Gambacorti-Passerini C, Orlov S, Zhang L, Braiteh F, Huang H, Esaki T, Horibe K, Ahn JS, Beck JT, Edenfield WJ, Shi Y, Taylor M, Tamura K, Van Tine BA, Wu SJ, Paolini J, Selaru P, Kim TM. Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study. Am J Hematol 2018;93:607-14. [PMID: 29352732 DOI: 10.1002/ajh.25043] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
36 Wu S, Xu R, Wan Q, Zhu X, Zhang L, Jiang H, Zhao X. Assessment of the potential diagnostic role of anaplastic lymphoma kinase for inflammatory myofibroblastic tumours: a meta-analysis. PLoS One 2015;10:e0125087. [PMID: 25910080 DOI: 10.1371/journal.pone.0125087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
37 Lee SJ, Park CK, Yang WI, Kim SK. IgG4-Related Sclerosing Mesenteritis. J Pathol Transl Med. 2016;50:309-311. [PMID: 26755359 DOI: 10.4132/jptm.2015.12.03] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
38 Murga-Zamalloa C, Lim MS. ALK-driven tumors and targeted therapy: focus on crizotinib. Pharmgenomics Pers Med 2014;7:87-94. [PMID: 24715763 DOI: 10.2147/PGPM.S37504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
39 Tsakiri K, Kotoula V, Lakis S, Müller J, Fostira F, Bobos M, Hytiroglou P, Fountzilas G. Crizotinib Failure in a TPM4-ALK –Rearranged Inflammatory Myofibroblastic Tumor With an Emerging ALK Kinase Domain Mutation. JCO Precision Oncology 2017. [DOI: 10.1200/po.17.00015] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
40 Ludwig K, Alaggio R, Dall'Igna P, Lazzari E, d'Amore ES, Chou PM. Omental mesenteric myxoid hamartoma, a subtype of inflammatory myofibroblastic tumor? Considerations based on the histopathological evaluation of four cases. Virchows Arch 2015;467:741-7. [PMID: 26386568 DOI: 10.1007/s00428-015-1842-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
41 Piva R, Pellegrino E, Mattioli M, Agnelli L, Lombardi L, Boccalatte F, Costa G, Ruggeri BA, Cheng M, Chiarle R, Palestro G, Neri A, Inghirami G. Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J Clin Invest 2006;116:3171-82. [PMID: 17111047 DOI: 10.1172/JCI29401] [Cited by in Crossref: 112] [Cited by in F6Publishing: 65] [Article Influence: 7.0] [Reference Citation Analysis]
42 Debiec-Rychter M, Croes R, De Vos R, Marynen P, Roskams T, Hagemeijer A, Lombaerts R, Sciot R. Complex genomic rearrangement of ALK loci associated with integrated human Epstein-Barr virus in a post-transplant myogenic liver tumor. Am J Pathol 2003;163:913-22. [PMID: 12937132 DOI: 10.1016/S0002-9440(10)63451-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
43 Reis-Filho JS. Re: Sastre-Garau et al. Inflammatory myofibroblastic tumour (inflammatory pseudotumour) of the breast: clinicopathological and genetic analysis of a case with evidence for clonality. J Pathol 2002; 196: 97-102. J Pathol 2003;200:269-71; author reply 271. [PMID: 12754748 DOI: 10.1002/path.1334] [Reference Citation Analysis]
44 Hornick JL, Sholl LM, Dal Cin P, Childress MA, Lovly CM. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors. Mod Pathol 2015;28:732-9. [PMID: 25612511 DOI: 10.1038/modpathol.2014.165] [Cited by in Crossref: 51] [Cited by in F6Publishing: 34] [Article Influence: 7.3] [Reference Citation Analysis]
45 Bagg A. Molecular diagnosis in lymphoma. Curr Oncol Rep 2004;6:369-79. [PMID: 15291980 DOI: 10.1007/s11912-004-0063-9] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
46 Zhao X, Yue C. Gastrointestinal stromal tumor. J Gastrointest Oncol 2012;3:189-208. [PMID: 22943011 DOI: 10.3978/j.issn.2078-6891.2012.031] [Cited by in F6Publishing: 41] [Reference Citation Analysis]
47 Cheng N, Chen J, Pan Y, Jiang Y, Zhou J, Shao C. Splenic hamartoma with bizarre stromal cells: a case report and literature review. Diagn Pathol. 2018;13:8. [PMID: 29378604 DOI: 10.1186/s13000-018-0687-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
48 Dobrosz Z, Ryś J, Paleń P, Właszczuk P, Ciepiela M. Inflammatory myofibroblastic tumor of the bladder - an unexpected case coexisting with an ovarian teratoma. Diagn Pathol 2014;9:138. [PMID: 25027562 DOI: 10.1186/1746-1596-9-138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
49 Tan LH, Do E, Tan SY, Chong SM, Koay ES. Multi-lineage interrogation of the performance characteristics of a split-signal fluorescence in situ hybridization probe for anaplastic lymphoma kinase gene rearrangements: a study of 101 cases characterized by immunohistomorphology on fixed archival tissue. Mol Diagn 2004;8:213-29. [PMID: 15887977 DOI: 10.1007/BF03260066] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Ribeiro MC, Lopes LR, de Souza Neto JC, Meirelles LR, de Carvalho RB, Andreollo NA. Rare gastric inflammatory myofibroblastic tumor in an adult woman: a case report with review of the literature. Case Rep Med 2012;2012:374070. [PMID: 22570660 DOI: 10.1155/2012/374070] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
51 Andraos E, Dignac J, Meggetto F. NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target. Cancers (Basel) 2021;13:E144. [PMID: 33466277 DOI: 10.3390/cancers13010144] [Reference Citation Analysis]
52 Korashy L, El-Zawahry H, Abdou S, Shahin D, Sherif F, Farrag W, Abdel-Khalik O, Salem H, El-Sebaaie A. Clinical Significance of ALK-1 Gene Abnormalities in Diffuse Large Cell Lymphoma. Clin Med Insights Oncol 2012;6:395-405. [PMID: 23239932 DOI: 10.4137/CMO.S9920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Papalas JA, Kulbacki E, Wang E. Anaplastic lymphoma kinase (ALK1) immunohistochemistry in diagnostic dermatopathology; an update. Am J Dermatopathol 2013;35:403-8; quiz 409-11. [PMID: 23689691 DOI: 10.1097/DAD.0b013e31823d2943] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
54 Qu LJ, Zhang HB, Gao J, Ge XX, Wang XZ. Clinicopathologic characteristics of intra-abdominal epithelioid inflammatory myofibroblastic sarcoma. Shijie Huaren Xiaohua Zazhi 2016; 24(15): 2438-2444 [DOI: 10.11569/wcjd.v24.i15.2438] [Reference Citation Analysis]
55 Baranov E, Hornick JL. Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck. Head Neck Pathol 2020;14:43-58. [PMID: 31950474 DOI: 10.1007/s12105-019-01104-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
56 de Montpréville VT, Zemoura L, Vaksmann G, Lecourt-Tierny G, Planché C, Dulmet E. Endocardial location of familial myofibromatosis revealed by cerebral embolization: cardiac counterpart of the frequent intravascular growth of the disease? Virchows Arch 2004;444:300-3. [PMID: 15024647 DOI: 10.1007/s00428-003-0938-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
57 Li J, Yin WH, Takeuchi K, Guan H, Huang YH, Chan JK. Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review. Diagn Pathol 2013;8:147. [PMID: 24034896 DOI: 10.1186/1746-1596-8-147] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
58 Yokoi H, Yazawa T, Matsumoto Y, Ikeda T, Fujiwara M, Ohkura Y, Kohno N. An Inflammatory Pseudotumor Arising from Pterygopalatine Fossa with Invasion to the Maxillary Sinus and Orbital Cavity. Case Rep Otolaryngol 2015;2015:950823. [PMID: 26167321 DOI: 10.1155/2015/950823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Iragavarapu C, Mustafa M, Akinleye A, Furqan M, Mittal V, Cang S, Liu D. Novel ALK inhibitors in clinical use and development. J Hematol Oncol 2015;8:17. [PMID: 25888090 DOI: 10.1186/s13045-015-0122-8] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 8.0] [Reference Citation Analysis]
60 Kataoka TR, Yamashita N, Furuhata A, Hirata M, Ishida T, Nakamura I, Hirota S, Haga H, Katsuyama E. An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall. World J Surg Oncol 2014;12:186. [PMID: 24938355 DOI: 10.1186/1477-7819-12-186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
61 Sekine A, Takahashi N, Watanabe T, Osawa Y, Ikeda T, Mori I, Kajita K, Morita H, Hirose Y, Seishima M, Ishizuka T. Adult intussusception of the descending colon due to inflammatory myofibroblastic proliferation. Clin J Gastroenterol 2012;5:74-8. [PMID: 26181880 DOI: 10.1007/s12328-011-0268-z] [Reference Citation Analysis]
62 Ma L, Wang K, Liu WK, Zhang YK. Is radical surgery necessary to head and neck inflammatory myofibroblastic tumor (IMT) in children? Childs Nerv Syst 2009;25:285-91. [PMID: 18830608 DOI: 10.1007/s00381-008-0718-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
63 Wang Z, Zhang L, Ren L, Liu D, Du J, Zhang M, Lou G, Song Y, Wang Y, Wu C, Han G. Distinct clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma: A report of four new cases and review of the literature. Thorac Cancer 2021;12:314-23. [PMID: 33314685 DOI: 10.1111/1759-7714.13727] [Reference Citation Analysis]
64 Kern JB, Hii A, Kruse MJ, Szabo Z, Argani P, Hibbard MK, Gladstone DE, Meyer C, Zheng R, Borowitz MJ, Duffield AS. A leukemic presentation of alveolar rhabdomyosarcoma in a 52-year-old woman without an identifiable primary tumor. Int J Surg Pathol 2015;23:75-7. [PMID: 25305220 DOI: 10.1177/1066896914553666] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]